Progranulin haploinsufficiency impairs lysosomal function via decreased TFEB nuclear translocation, causing lipofuscin accumulation and neuronal vulnerability. Enhancing TFEB activity may restore lysosomal homeostasis. However, GRN Phase 3 (latozinemab) failed clinically, and direct TFEB activation poses oncogenic/metabolic risks.
No linked papers recorded for this hypothesis yet.
No curated PDB or AlphaFold mapping for TFEB yet. Search RCSB →
No clinical trials data linked to this hypothesis yet.
No curated ClinVar variants loaded for this hypothesis.
Run scripts/backfill_clinvar_variants.py to fetch P/LP/VUS variants.
No DepMap CRISPR Chronos data found for TFEB.
Run python3 scripts/backfill_hypothesis_depmap.py to populate.
No resource usage or linked notebooks recorded for this hypothesis yet.